About Us
At DINSO-MX. we develop scientifically validated biotechnologies transforming tissue regeneration across human, veterinary, and cosmetic health
Our Story
From the Laboratory to the Hospital
The Origin – A Shared Vision
In 2015, a group of researchers passionate about advanced biomaterials joined forces at prestigious institutions including CINVESTAV, CIDESI. During their graduate studies, they identified a critical gap in the biomedical sector: the lack of high-quality, affordable, locally developed options for bone and tissue regeneration.
This unmet need sparked a collaborative mission — to design innovative, disruptive solutions with the power to transform regenerative medicine in Latin America and beyond.
From Research to Commercial
After years of scientific development, DINSO-MX was officially founded in 2023 with the goal of commercializing cutting-edge regenerative medicine technologies.
That same year, the company patented an innovative synthesis process for calcium sodium silicophosphates — a new generation of bioactive ceramics with osteoinductive, osteoconductive, and angiogenic properties. This breakthrough set the foundation for scalable, industrial-grade biomaterials.
Veterinary Innovation & Market Leadership
DINSO-MX quickly made its mark in the veterinary sector with the launch of TR-Vet, a specialized line for animal bone regeneration. Products like BH-Vet and BH-Vet XS brought affordable, effective regenerative solutions to clinics across the region.
This success solidified DINSO-MX as a leader in synthetic biomaterials, with international distribution in Mexico, Colombia, Peru, Brazil, Argentina, and Costa Rica.
The Future – Expansion into Human Medicine
Building on its veterinary success, DINSO-MX is preparing for its next major milestone: the 2026 launch of AH-Bone, a bioactive bone filler certified for human medical use.
This will mark the company’s official entry into the healthcare sector, aiming to democratize access to advanced regenerative technologies for clinicians and patients across Latin America.
From Scientific Vision to Global Impact
Generation of knowledge in advanced biomaterials and academic training in institutions such as CINVESTAV, CIDESI.
DINSO-MX Foundation to commercialize innovations in regenerative medicine.
Patent of the process for the synthesis of sodium calcium silicophosphates.
Launch of TR-Vet, with the flagship product BH-Vet, a high-performance synthetic bone filler.
International expansion with product distribution in Mexico, Colombia, Peru, and Brazil.
Presentation of BH-Vet XS, with applications in bone infections such as osteomyelitis through prolonged release of antibiotics.
DINSO-MX expansion to Argentina and Costa Rica.
Entering the human market with AH-Bone, a bioactive bone filler certified for medical use.
Be part of the biomedical revolution. Our patented bioceramic and 3D bioprinting technology is transforming hard and soft tissue regeneration.
CONTACT US